Premier Fund Managers’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-250,099
Closed -$38.9M 175
2025
Q1
$38.9M Buy
250,099
+99
+0% +$16.6K 1.45% 32
2024
Q4
$45.8M Hold
250,000
1.63% 31
2024
Q3
$49.6M Buy
250,000
+90,000
+56% +$18.7M 1.76% 28
2024
Q2
$33.2M Hold
160,000
1.33% 35
2024
Q1
$43.1M Sell
160,000
-44,000
-22% -$10.5M 1.71% 30
2023
Q4
$48.7M Sell
204,000
-16,000
-7% -$3.15M 2.1% 20
2023
Q3
$43M Hold
220,000
2.02% 24
2023
Q2
$46M Hold
220,000
1.83% 23
2023
Q1
$43.6M Hold
220,000
1.72% 29
2022
Q4
$49.2M Buy
220,000
+109,000
+98% +$23.8M 1.92% 17
2022
Q3
$21.1M Buy
111,000
+70,000
+171% +$15.1M 1.58% 27
2022
Q2
$8.99M Hold
41,000
0.4% 69
2022
Q1
$11.9M Sell
41,000
-39,300
-49% -$12.1M 0.42% 71
2021
Q4
$30.2M Sell
80,300
-16,200
-17% -$6.29M 0.97% 43
2021
Q3
$40.9M Sell
96,500
-900
-0.9% -$374K 1.32% 28
2021
Q2
$36.2M Buy
97,400
+5,800
+6% +$1.94M 1.23% 37
2021
Q1
$26.4M Hold
91,600
1.02% 38
2020
Q4
$22.8M Hold
91,600
0.98% 38
2020
Q3
$20.4M Hold
91,600
1.17% 32
2020
Q2
$16M Buy
+91,600
New +$14.6M 0.99% 40

Other funds holding CRL

Premier Fund Managers's CRL Position: Q2 2025 in Review

Premier Fund Managers sold out of Charles River Laboratories (CRL) in Q2 2025, closing a stake of 250,099 shares — an estimated $38.9M sold.

Premier Fund Managers first reported a position in CRL in Q2 2020 and held it in 20 quarters. The position peaked at $49.6M in Q3 2024. 519 funds tracked by Wall St. Rank hold CRL as of Q2 2025.

  • Premier Fund Managers reported no remaining Charles River Laboratories position as of Q2 2025 after selling out during the quarter.
  • Premier Fund Managers sold 250,099 Charles River Laboratories shares in Q2 2025, an estimated $38.9M.
  • Premier Fund Managers first reported a position in Charles River Laboratories in Q2 2020 and held it in 20 quarters.
  • Premier Fund Managers's Charles River Laboratories position peaked at $49.6M in Q3 2024.
  • 519 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2025.

Based on Premier Fund Managers's 13F filing for Q2 2025, filed 11 Aug 2025.